Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 156,190 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 156,190 shares of the firm’s stock in a transaction on Thursday, January 8th. The shares were bought at an average cost of $0.52 per share, for a total transaction of $81,218.80. Following the acquisition, the chief executive officer owned 7,131,794 shares in the company, valued at approximately $3,708,532.88. The trade was a 2.24% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, January 7th, Grigorios Siokas bought 124,880 shares of Cosmos Health stock. The stock was bought at an average cost of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas bought 133,953 shares of Cosmos Health stock. The shares were bought at an average price of $0.54 per share, for a total transaction of $72,334.62.
• On Friday, December 19th, Grigorios Siokas purchased 88,314 shares of Cosmos Health stock. The shares were bought at an average cost of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The stock was bought at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The stock was bought at an average price of $0.64 per share, with a total value of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.63 per share, for a total transaction of $35,111.16.
• On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The stock was purchased at an average price of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.62 per share, with a total value of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas bought 61,614 shares of Cosmos Health stock. The shares were purchased at an average price of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Price Performance

Cosmos Health stock opened at $0.55 on Friday. The business’s 50-day simple moving average is $0.57 and its 200 day simple moving average is $0.73. The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. The stock has a market cap of $20.58 million, a price-to-earnings ratio of -0.73 and a beta of 5.37. Cosmos Health Inc. has a 12-month low of $0.28 and a 12-month high of $1.32.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The firm had revenue of $17.11 million for the quarter, compared to the consensus estimate of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. As a group, research analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Wall Street Zen raised shares of Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC grew its position in Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the period. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. 12.61% of the stock is owned by institutional investors and hedge funds.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.